On-Demand Pumping

On-demand dosing in a package small enough to be easily implanted in wide range of animals.


Improves safety for animals and handlers, ideal for chronic treatments lasting several weeks.


Electronic dosing control simplifies your work and allows for a wide range of dosing regimen.



 Perform experiments with complete dosing flexibility


Flexible Dosing Options

The FluidSync™ microinfusion technology supports a wide variety of dosing profiles and offers users complete control over their dosing regiment. Some advantages include:

  • Discrete bolus dosing
  • Continuous flow rate
  • Reprogrammable automation
  • On-demand activation

Pump on Finger


Wide Range of Applications

The FluidSync™ microinfusion technology is suited for a wide range of animals, drugs, and dosing requirements.

Latest News

  • NSF Conference: Fluid Synchrony will attend and present at the NSF SBIR/STTR Phase II Grantee Conference in Atlanta, GA. (6/3/15)
  • NIH Phase I: Fluid Synchrony awarded 2-year NIH SBIR Phase I grant. (5/11/15)
  • SOT Conference: Fluid Synchrony to present latest in-vivo test data at SOT’s 54th Annual Meeting, March 22–26, 2015, at the San Diego Convention Center. (2/2/15)
  • UCLA Conference: Fluid Synchrony invited to present at UCLA’s 3rd Annual Medical Device Partnering Conference on March 10, 2015. (1/25/15)
  • NSF Phase II Supplemental: Fluid Synchrony awarded NSF SBIR Phase II supplemental grant. (8/15/14)
  • NSF Phase II: Fluid Synchrony awarded 2-year NSF SBIR Phase II grant. (4/15/14)
  • NIH Phase I: Fluid Synchrony awarded 2-year NIH Lab-to-Marketplace SBIR Phase I grant. (9/15/14)
  • NSF Phase IB: Fluid Synchrony awarded NSF SBIR Phase IB grant. (7/1/14)
  • New HQ: New Fluid Synchrony headquarters opens in the heart of downtown LA! (7/1/14)
  • NSF Phase I: Fluid Synchrony awarded NSF SBIR Phase I award. (1/1/13)

News Archive